26 research outputs found
The changing pattern of human brucellosis: clinical manifestations, epidemiology, and treatment outcomes over three decades in Georgia
<p>Abstract</p> <p>Background</p> <p>Brucellosis is an endemic infection in Georgia. We conducted a review of patient records with a suspected or confirmed diagnosis of brucellosis over three decades at the central referral hospital for brucellosis cases, the Institute of Parasitology and Tropical Medicine (IPTM) in Tbilisi. The purpose was to describe the demographic profile and clinical characteristics as well as diagnostic and treatment strategies in patients with brucellosis.</p> <p>Methods</p> <p>Data were abstracted from randomly selected patient records at the IPTM. In total, 300 records were reviewed from three time periods: 1970-73, 1988-89, and 2004-2008.</p> <p>Results</p> <p>The age distribution of patients shifted from a median age of 40 years in the first time period to 20 years in the third time period. Azeri ethnicity was an increasing proportion of the total number of cases. The frequency of relapsed infection was 14.7% (44 cases). A total of 50 patients received vaccine therapy, and although the vaccine produced immune responses, demonstrated by an increase in agglutination titers, it was not associated with improved outcome.</p> <p>Conclusion</p> <p>The demographics of brucellosis in Georgia fit a profile of persons that tend sheep. Osteoarticular complications were commonly detected, especially in children. The changing pattern of brucellosis in Georgia suggests clinicians should be updated about different trends in brucellosis in their country.</p
Poor performance of the rapid test for human brucellosis in health facilities in Kenya
Human brucellosis is considered to be an important but typically under-diagnosed cause of febrile illness in many low and middle-income countries. In Kenya, and throughout East Africa, laboratory diagnosis for the disease is based primarily on the febrile antigen Brucella agglutination test (FBAT), yet few studies of the diagnostic accuracy of this test exist. Assessment of the performance of the FBAT is essential for its appropriate clinical use, as well as for evaluating surveillance data reported by public health systems. To assess FBAT performance, we collected sera from people with symptoms compatible with brucellosis attending two health facilities in Busia County, Kenya. Sera were tested using the FBAT and results compared with those from the Rose Bengal Test (RBT), an assay with well-known performance characteristics. Positives on either test were confirmed using the classical serum agglutination test (SAT)-Coombs test combination and a rapid IgM/IgG lateral flow immunochromatography assay (LFA). A questionnaire focussing on known risk factors for exposure to Brucella spp. was also conducted, and relationships with FBAT positivity examined using logistic regression. Out of 825 recruited individuals, 162 (19.6%) were classified as positive using the FBAT. In contrast, only eight (1.0%) were positive using the RBT. Of the 162 FBAT positives, one (0.62%) had an atypical agglutination in SAT and three (1.9%) showed low Coombs titres. Out of 148 FBAT positive individuals tested using the LFA, five (3.4%) were IgM positive and none were IgG positive. Poor or no correlation was observed between FBAT results and most established risk factors for Brucella infection. We observed substantial disagreement between the FBAT and a number of well-known serological tests, with the majority of reactive FBAT results appearing to be false positives. Poor FBAT specificity, combined with a lack of confirmatory testing, strongly suggests overdiagnosis of brucellosis is common in this low prevalence setting. This is expected to have important economic impacts on affected patients subjected to the long and likely unnecessary courses of multiple antibiotics required for treatment of the disease
Comparison of a Flow Assay for Brucellosis Antibodies with the Reference cELISA Test in West African Bos indicus
Brucellosis is considered by the Food and Agricultural Organisation and the World Health Organisation as one of the most widespread zoonoses in the world. It is a major veterinary public health challenge as animals are almost exclusively the source of infection for people. It is often undiagnosed in both human patients and the animal sources and it is widely acknowledged that the epidemiology of brucellosis in humans and animals is poorly understood, particularly in sub-Saharan Africa. It is therefore important to develop better diagnostic tools in order to improve our understanding of the epidemiology and also for use in the field for disease control and eradication. As with any new diagnostic test, it is essential that it is validated in as many populations as possible in order to characterise its performance and improve the interpretation of its results. This paper describes a comparison between a new lateral flow assasy (LFA) for bovine brucellosis and the widely used cELISA in a no gold standard analysis to estimate test performance in this West African cattle population. A Bayesian formulation of the Hui-Walter latent class model incorporated previous studies' data on sensitivity and specificity of the cELISA. The results indicate that the new LFA is very sensitive (∼87%) and highly specific (∼97%). The analysis also suggests that the current cut-off of the cELSIA may not be optimal for this cattle population but alternative cut-offs did not significantly change the estimates of the LFA. This study demonstrates the potential usefulness of this simple to use test in field based surveillance and control which could be easily adopted for use in developing countries with only basic laboratory facilities
Review of clinical and laboratory features of human Brucellosis
Infection with Brucella spp. continues to pose a human health risk
globally despite strides in eradicating the disease from domestic
animals. Brucellosis has been an emerging disease since the discovery
of Brucella melitensis by Sir David Bruce in 1887. Although many
countries have eradicated B. abortus from cattle, in some areas B.
melitensis and B. suis have emerged as causes of this infection in
cattle, leading to human infections. Currently B. melitensis remains
the principal cause of human brucellosis worldwide including India. The
recent isolation of distinct strains of Brucella from marine mammals
as well as humans is an indicator of an emerging zoonotic disease.
Brucellosis in endemic and non-endemic regions remains a diagnostic
puzzle due to misleading non-specific manifestations and increasing
unusual presentations. Fewer than 10% of human cases of brucellosis may
be clinically recognized and treated or reported. Routine serological
surveillance is not practiced even in Brucella - endemic countries and
we suggest that this should be a part of laboratory testing coupled
with a high index of clinical suspicion to improve the level of case
detection. The screening of family members of index cases of acute
brucellosis in an endemic area should be undertaken to pick up
additional unrecognised cases. Rapid and reliable, sensitive and
specific, easy to perform and automated detection systems for Brucella
spp. are urgently needed to allow early diagnosis and adequate
antibiotic therapy in time to decrease morbidity / mortality. The
history of travel to endemic countries along with exposure to animals
and exotic foods are usually critical to making the clinical diagnosis.
Laboratory testing is indispensable for diagnosis. Therefore alertness
of clinician and close collaboration with microbiologist are essential
even in endemic areas to correctly diagnose and treat this protean
human infection. Existing treatment options, largely based on
experience gained > 30 years ago, are adequate but not optimal. In
our experience, an initial combination therapy with a three
drug-regimen followed by a two-drug regimen for at least six weeks and
a combination of two drugs with a minimum of six weeks seems warranted
to improve outcome in children and adult patients respectively with
laboratory monitoring. A safe and effective vaccine in humans is not
yet available. Prevention is dependent upon the control of the disease
in animal hosts, effective heat treatment of dairy produce and hygienic
precautions to prevent occupational exposure. This review compiles the
experiences and diagnostic and treatment paradigms currently employed
in fighting this disease
Meningitis due to Rhodotorula glutinis in an HIV infected patient
Rhodotorula spp, though considered a common saprophyte, recently has
been reported as causative agent of opportunistic mycoses. We present a
case of meningitis in an immunocompromised human immunodeficiency virus
infected patient who presented with longstanding fever. He was
diagnosed as a case of chronic meningitis. Diagnosis was confirmed by
cell cytology, India ink preparation, Gram staining and culture of
cerebrospinal fluid (CSF) sample. CSF culture grew Rhodotorula glutinis
. Therapy with amphotericin B was successful in eliminating the yeast
from CSF and the patient was discharged after recovery